Enoxaparin sodium and Ritonavir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Enoxaparin sodium (enoxaparin sodium) and Ritonavir (ritonavir). Common drug interactions include abdominal pain upper among females and benign prostatic hyperplasia among males.
The phase IV clinical study analyzes what interactions people have when they take Enoxaparin sodium and Ritonavir. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.
What is Enoxaparin sodium?
Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.
What is Ritonavir?
Ritonavir has active ingredients of ritonavir. eHealthMe is studying from 13,036 Ritonavir users. Check the latest studies of Ritonavir.
25 people who take Enoxaparin sodium and Ritonavir together, and have interactions are studied.

What are the common drug interactions of Enoxaparin Sodium and Ritonavir, by gender? *:
female:
- Abdominal pain upper
- Pyrexia (fever)
- Abdominal pain
- Abdominal tenderness
- Anxiety
- Arthralgia (joint pain)
- Bile duct stone
- Biliary dilatation
- Cholangitis (infection of the bile duct)
- Cholecystitis (infection of gallbladder)
male:
- Benign prostatic hyperplasia (benign enlargement of the prostate)
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- Disease progression
- Drug ineffective
- Erythema (redness of the skin)
- Lymphocyte count decreased
- Urinary retention (the inability to completely or partially empty the bladder)
- White blood cell count decreased
- Constipation
- Dysuria (painful or difficult urination)
What are the common drug interactions of Enoxaparin Sodium and Ritonavir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Haemorrhage (bleeding)
- Pulmonary embolism (blockage of the main artery of the lung)
- Pulmonary thrombosis (scarring in the lungs)
- Renal vascular thrombosis (blood clot in kidney blood vessels)
30-39:
- Anxiety
- Arthralgia (joint pain)
- Depression
- Emotional distress
- Fracture
- Fractured sacrum
- Gait disturbance
- Hip fracture
- Joint dislocation (a joint position is changed from normal position)
- Joint injury
40-49:
- Drug ineffective
50-59:
- Acute respiratory distress syndrome
- Blood fibrinogen increased
- Disease progression
- Erythema multiforme (a type of hypersensitivity reaction)
- Lymphocyte count decreased
- Neutropenia (an abnormally low number of neutrophils)
- Rash
- White blood cell count decreased
60+:
- Benign prostatic hyperplasia (benign enlargement of the prostate)
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- Acute generalised exanthematous pustulosis (acute febrile drug eruption)
- Anaemia (lack of blood)
- Bile duct stone
- Biliary dilatation
- Cholangitis (infection of the bile duct)
- Cholecystitis (infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Crepitations (noises are produced by the rubbing of parts one against the other)
What are the existing conditions these people have? *
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 24.00%
- Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 6 people, 24.00%
- Back Pain: 6 people, 24.00%
- Adverse Event: 6 people, 24.00%
- Abdominal Pain: 6 people, 24.00%
- Constipation: 5 people, 20.00%
- Fever: 3 people, 12.00%
- Cough: 3 people, 12.00%
- Hypoglycemia (low blood sugar): 2 people, 8.00%
- Hiv Infection: 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Enoxaparin sodium and Ritonavir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Enoxaparin sodium (24,181 reports)
- Ritonavir (13,036 reports)
Browse all drug interactions of Enoxaparin sodium and Ritonavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Enoxaparin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ritonavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Enoxaparin sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ritonavir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium and ritonavir (the active ingredients of Enoxaparin sodium and Ritonavir, respectively), and Enoxaparin sodium and Ritonavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mucormycosis and drugs of ingredients of cyclophosphamide - 2 seconds ago
- Could Ultram Er cause Abdominal Pain Aggravated? - 2 seconds ago
- Overdose and drugs of ingredients of enzalutamide - 5 seconds ago
- Drug interactions of Amaryl and Mometasone Furoate - 7 seconds ago
- Exforge vs. Olmesartan Medoxomil, side effect and effectiveness comparison - 8 seconds ago
- Could Aubagio cause Eye Pain? - 9 seconds ago
- Could Acetaminophen cause Renal Tubular Acidosis? - 10 seconds ago
- Fosamax and Ceftazidime drug interactions for women aged 60+ - 11 seconds ago
- Hypotonia and drugs of ingredients of insulin pork - 13 seconds ago
- Androgel vs. Daytrana, side effect and effectiveness comparison - 15 seconds ago